Effect of exogenous expression of IFN-γ on the new world alphavirus replication and infection
Abstract
Aim: IFN-γ plays an important role in control of the old world alphavirus infection. However, the role of IFN-γ in the infection by the new world alphaviruses is not well characterized. Materials & methods: Ad5-mIFN-γ, a recombinant, replication-deficient human adenovirus, was constructed to express mouse IFN-γ (mIFN-γ) and a mouse, lethal challenge model of the new world alphavirus western equine encephalitis virus (WEEV) was used. Results: A single-dose injection of Ad5-mIFN-γ produced a high level of mIFN-γ in mice. Cells inoculated with Ad5-mIFN-γ restricted the replication of WEEV. A single-dose injection of Ad5-mIFN-γ delayed the WEEV infection and extended the survival time in mice. Conclusion: IFN-γ restricts the WEEV infection.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Interferons: success in anti-viral immunotherapy. Cytokine Growth Factor Rev. 25(4), 369–376 (2014).
- 2. . Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75(2), 163–189 (2004). • An overview covering the well-characterized responses of IFN-γ that alter macrophage function during infection.
- 3. . Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts. J. Virol. 82(4), 1934–1945 (2008).
- 4. . Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 76(22), 11541–11550 (2002).
- 5. . Interferon gamma inhibits varicella-zoster virus replication in a cell line-dependent manner. J. Virol. 93(12), 1–16 (2019).
- 6. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35(3), 694–703 (2002).
- 7. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J. Virol. 81(13), 7124–7135 (2007).
- 8. . Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. J. Virol. 79(12), 7768–7776 (2005).
- 9. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J. Virol. 71(7), 5227–5235 (1997).
- 10. . Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl Acad. Sci. USA 95(26), 15623–15628 (1998).
- 11. . Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261(5127), 1445–1448 (1993). •• Demonstrated that the direct inhibition of viral replication by IFN-γ is through induction of nitric oxide synthase.
- 12. . Innate responses to viral infections. In: Fields Virology. Knipe DM Howley PM (Eds). Lippincott Williams & Wilkins, PA, USA, 249–278 (2007).
- 13. . Cell type-specific signaling in response to interferon-gamma. Curr. Top. Microbiol. Immunol. 316, 119–154 (2007).
- 14. . The old world and new world alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J. Virol. 81(5), 2472–2484 (2007).
- 15. . Alphaviruses. In: Fields Virology. Knipe DM Howley PM (Eds). Lippincott Williams & Wilkins, PA, USA, 1023–1067 (2007).
- 16. . Alphaviruses. In: Biodefense: Research Methodology and Animal Models. Swearengen JR (Ed.). CRC Press, FL, USA, 181–206 (2006).
- 17. . Venezuelan equine encephalitis. Annu. Rev. Entomol. 49, 141–174 (2004).
- 18. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia. J. Infect. Dis. 175(4), 828–832 (1997).
- 19. . Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 293(5528), 303–306 (2001). •• Showed first time that T cells used IFN-γ to clear the old world alphaviurs infection in the CNS.
- 20. . Gamma interferon-dependent, noncytolytic clearance of sindbis virus infection from neurons in vitro . J. Virol. 79(9), 5374–5385 (2005).
- 21. . Mice deficient in interferon-gamma or interferon-gamma receptor 1 have distinct inflammatory responses to acute viral encephalomyelitis. PLoS ONE 8(10), 1–13 (2013).
- 22. . Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system. J. Virol. 81(11), 5628–5636 (2007).
- 23. . Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis. J. Gen. Virol. 97(11), 2908–2925 (2016).
- 24. . Non-pathogenic Sindbis virus causes hemorrhagic fever in the absence of alpha/beta and gamma interferons. Virology 368(2), 273–285 (2007).
- 25. Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine. Genes Dis. 4(2), 43–63 (2017).
- 26. Infectivity variation and genetic diversity among strains of Western equine encephalitis virus. J. Gen. Virol. 87(Pt 8), 2353–2361 (2006).
- 27. Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine. Vaccine 25(22), 4368–4375 (2007).
- 28. . A simplified system for generating recombinant adenoviruses. Proc. Natl Acad. Sci. USA 95(5), 2509–2514 (1998).
- 29. . Virology Methods Manual. Academic Press, CA, USA (1996).
- 30. . Pre- and post-exposure protection against western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha. Virology 369(1), 206–213 (2007). • Demonstrated that adenovirus-mediated IFN-γ gene therapy has a potential to be used as a single-dose regime to prevent the lethal infection of a new world alphavirus.
- 31. . Review paper: pathology of animal models of alphavirus encephalitis. Vet. Pathol. 47(5), 790–805 (2010). •• A review paper to summarize the current animal models for the new world alphaviruses.
- 32. . The role of IFN-γamma in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev. 13(6), 441–454 (2002). • A review on the mechanism of IFN-γ mediated antiviral effect on viral infections of the CNS.
- 33. . Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68(1–2), 101–108 (1996).
- 34. . Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol. 3(6), 493–502 (2003). • A detailed review on the roles of cytotoxic T cells, antibodies and cytokines in the clearance of viral infection from neurons, glial cells and meningeal cells.
- 35. . Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Virology 257(1), 106–118 (1999).
- 36. . Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells. J. Gen. Virol. 72(Pt 4), 809–815 (1991).
- 37. . Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J. Virol. 81(20), 11246–11255 (2007). • Demonstrated that several interferon-stimulated proteins are responsible for the antiviral effect of interferons against the alphaviruses.
- 38. Structural and nonstructural protein genome regions of eastern equine encephalitis virus are determinants of interferon sensitivity and murine virulence. J. Virol. 82(10), 4920–4930 (2008).
- 39. . Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man. Am. J. Trop. Med. Hyg. 16(6), 762–768 (1967).
- 40. . Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5´ untranslated region. J. Virol. 75(8), 3706–3718 (2001).
- 41. . The 5´UTR-specific mutation in VEEV TC-83 genome has a strong effect on RNA replication and subgenomic RNA synthesis, but not on translation of the encoded proteins. Virology 387(1), 211–221 (2009).
- 42. . Recombinant human interferon-gamma inhibits adenovirus multiplication without modifying viral penetration. J. Gen. Virol. 68(Pt 10), 2675–2679 (1987).
- 43. . Recombinant human interferon-gamma inhibits adenovirus multiplication in vitro . J. Gen. Virol. 68(Pt 3), 941–944 (1987).
- 44. Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system. J. Virol. 77(18), 10078–10087 (2003).
- 45. . Delivery of peptide drugs to the brain by adenovirus-mediated heterologous expression of human oligopeptide transporter at the blood–brain barrier. J. Pharmacol. Exp. Ther. 305(1), 40–407 (2003).
- 46. Directing adenovirus across the blood–brain barrier via melanotransferrin (P97) transcytosis pathway in an in vitro model. Gene Ther. 14(6), 523–532 (2007).
- 47. . Similarities and differences in antagonism of neuron alpha/beta interferon responses by Venezuelan equine encephalitis and Sindbis alphaviruses. J. Virol. 83(19), 10036–10047 (2009).